Combined use of dopamine transporter imaging (DAT-SPECT) and 123 I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease
Combined use of dopamine transporter imaging (DAT-SPECT) and 123 I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy for diagnosing Parkinson's disease
Authors
Keywords
Parkinson's disease, I-FP-CIT SPECT (DAT-SPECT), I-MIBG myocardial scintigraphy, Specific binding ratio (SBR), Heart to mediastinum (H/M) ratio, SWEDDs (scans without evidence of dopaminergic deficits)
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started